ENVISTA HOLDINGS CORPORATION Impairment of Intangible Assets, Finite-lived
ENVISTA HOLDINGS CORPORATION (NVST) reported Impairment of Intangible Assets, Finite-lived of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsFinitelived · last filed 2026-02-12
- ENVISTA HOLDINGS CORPORATION impairment of intangible assets, finite-lived for the quarter ending 2023-12-31 was -$300.00K.
- ENVISTA HOLDINGS CORPORATION impairment of intangible assets, finite-lived for the quarter ending 2023-09-29 was $100.00K, a 88.89% decline year-over-year.
- ENVISTA HOLDINGS CORPORATION impairment of intangible assets, finite-lived for the quarter ending 2023-06-30 was -$100.00K, a 110.00% decline year-over-year.
- ENVISTA HOLDINGS CORPORATION impairment of intangible assets, finite-lived for the quarter ending 2023-03-31 was $300.00K, a 92.31% decline year-over-year.
- ENVISTA HOLDINGS CORPORATION impairment of intangible assets, finite-lived for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- ENVISTA HOLDINGS CORPORATION impairment of intangible assets, finite-lived for fiscal 2024 was $92.20M.
- ENVISTA HOLDINGS CORPORATION impairment of intangible assets, finite-lived for fiscal 2023 was $0.00.
- ENVISTA HOLDINGS CORPORATION impairment of intangible assets, finite-lived for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Impairment of Intangible Assets, Finite-lived 3 month | Impairment of Intangible Assets, Finite-lived 6 month | Impairment of Intangible Assets, Finite-lived 9 month | Impairment of Intangible Assets, Finite-lived 12 month | Impairment of Intangible Assets, Finite-lived 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-12 | ||||
| 2024-12-31 | $92.20M 10-K · filed 2026-02-12 | ||||
| 2023-12-31 | -$300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | -$200.00K derived: sum of 2 quarters · filed 2026-02-12 | -$300.00K derived: sum of 3 quarters · filed 2026-02-12 | $0.00 10-K · filed 2026-02-12 | |
| 2023-09-29 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $0.00 derived: sum of 2 quarters · filed 2023-11-01 | $300.00K 10-Q · filed 2023-11-01 | -$5.50M derived: sum of 4 quarters · filed 2025-02-13 | |
| 2023-06-30 | -$100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $200.00K 10-Q · filed 2023-08-02 | -$5.60M derived: sum of 3 quarters · filed 2025-02-13 | -$4.70M derived: sum of 4 quarters · filed 2025-02-13 | |
| 2023-03-31 | $300.00K 10-Q · filed 2023-05-03 | -$5.50M derived: sum of 2 quarters · filed 2025-02-13 | -$4.60M derived: sum of 3 quarters · filed 2025-02-13 | -$3.60M derived: sum of 4 quarters · filed 2025-02-13 | |
| 2022-12-31 | -$5.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | -$4.90M derived: sum of 2 quarters · filed 2025-02-13 | -$3.90M derived: sum of 3 quarters · filed 2025-02-13 | $0.00 10-K · filed 2025-02-13 | $6.40M 10-K · filed 2023-02-16 |
| 2022-09-30 | $900.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $1.90M derived: sum of 2 quarters · filed 2023-11-01 | $5.80M 10-Q · filed 2023-11-01 | $14.80M derived: sum of 4 quarters · filed 2023-11-01 | |
| 2022-07-01 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $4.90M 10-Q · filed 2023-08-02 | $13.90M derived: sum of 3 quarters · filed 2023-08-02 | $19.20M derived: sum of 4 quarters · filed 2023-08-02 | |
| 2022-04-01 | $3.90M 10-Q · filed 2023-05-03 | $12.90M derived: sum of 2 quarters · filed 2023-05-03 | $18.20M derived: sum of 3 quarters · filed 2023-05-03 | $20.40M derived: sum of 4 quarters · filed 2023-05-03 | |
| 2021-12-31 | $9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $14.30M derived: sum of 2 quarters · filed 2023-02-16 | $16.50M derived: sum of 3 quarters · filed 2023-02-16 | $18.40M 10-K · filed 2023-02-16 | |
| 2021-10-01 | $5.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $7.50M derived: sum of 2 quarters · filed 2022-11-03 | $9.40M 10-Q · filed 2022-11-03 | $24.90M derived: sum of 4 quarters · filed 2023-02-16 | |
| 2021-07-02 | $2.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $4.10M 10-Q · filed 2022-08-03 | $19.60M derived: sum of 3 quarters · filed 2023-02-16 | $26.40M derived: sum of 4 quarters · filed 2023-02-16 | |
| 2021-04-02 | $1.90M 10-Q · filed 2022-05-04 | $17.40M derived: sum of 2 quarters · filed 2023-02-16 | $24.20M derived: sum of 3 quarters · filed 2023-02-16 | $34.50M derived: sum of 4 quarters · filed 2023-02-16 | |
| 2020-12-31 | $15.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $22.30M derived: sum of 2 quarters · filed 2023-02-16 | $32.60M derived: sum of 3 quarters · filed 2023-02-16 | $32.60M 10-K · filed 2023-02-16 | |
| 2020-10-02 | $6.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $17.10M derived: sum of 2 quarters · filed 2021-11-03 | $17.10M 10-Q · filed 2021-11-03 | $17.10M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-07-03 | $10.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $10.30M 10-Q · filed 2021-08-03 | $10.30M derived: sum of 3 quarters · filed 2022-02-24 | $10.30M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-04-03 | $0.00 10-Q · filed 2021-05-05 | $0.00 derived: sum of 2 quarters · filed 2022-02-24 | $0.00 derived: sum of 3 quarters · filed 2022-02-24 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $0.00 derived: sum of 2 quarters · filed 2022-02-24 | $0.00 10-K · filed 2022-02-24 | ||
| 2019-09-27 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $0.00 10-Q · filed 2020-10-29 | |||
| 2019-06-28 | $0.00 10-Q · filed 2020-07-30 | ||||
| 2018-12-31 | $400.00K 10-K · filed 2021-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DENTSPLY SIRONA Inc. (XRAY) | United States | $1.900B | -3.87 |